{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:05:04Z","timestamp":1791421504239,"version":"4.3.3"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021953","name":"Royal Society Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016050","name":"Department of Environment and Heritage Protection, Queensland Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001796","name":"University of the Sunshine Coast","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003550","name":"Queensland Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tim.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:13:20Z","timestamp":1774268000000},"page":"601-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Koalas first: lessons from a wildlife Chlamydia vaccine"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8437-3303","authenticated-orcid":false,"given":"Nina M.","family":"Pollak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2026.02.003_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.tim.2026.02.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107861","article-title":"Innovative approach for the clinical development of a Chlamydia trachomatis vaccine through a human challenge model in women","volume":"154","author":"Cohen","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective chlamydial vaccine: lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/infdis\/jiab610","article-title":"Problems with understanding Chlamydia trachomatis immunology","volume":"225","author":"Brunham","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0025","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","article-title":"An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial","volume":"24","author":"Pollock","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?","volume":"20","author":"de la Maza","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tim.2026.02.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/963513","article-title":"Chlamydia trachomatis vaccine research through the years","volume":"2011","author":"Schautteet","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.tim.2026.02.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftae017","article-title":"Advances in vaccine development for Chlamydia trachomatis","volume":"82","author":"Poston","year":"2024","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0055","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14760584.2022.2117694","article-title":"Chlamydia trachomatis vaccine development\u2014a view on the current challenges and how to move forward","volume":"21","author":"Borges","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tim.2026.02.003_bb0060","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/652402","article-title":"Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies","volume":"201","author":"Geisler","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.38.9.1937","article-title":"Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin","volume":"38","author":"Beale","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tim.2026.02.003_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0897.2009.00776.x","article-title":"A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants","volume":"63","author":"Carey","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.tim.2026.02.003_bb0075","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/IAI.67.10.5518-5521.1999","article-title":"Role of gamma interferon in controlling murine chlamydial genital tract infection","volume":"67","author":"Ito","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tim.2026.02.003_bb0080","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0085","series-title":"Permit to Allow Minor Use and Supply of an Unregistered AgVet Chemical Product: PER94984 (KLAVAX\u2014Tr\u00e9idlia Koala Chlamydia Vaccine)","author":"Australian Pesticides and Veterinary Medicines Authority (APVMA)","year":"2025"},{"key":"10.1016\/j.tim.2026.02.003_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1447119","article-title":"Koala ocular disease grades are defined by chlamydial load changes and increases in Th2 immune responses","volume":"14","author":"Phillips","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tim.2026.02.003_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetmic.2013.02.026","article-title":"Recent advances in understanding the biology, epidemiology and control of chlamydial infections in koalas","volume":"165","author":"Polkinghorne","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.tim.2026.02.003_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1751-0813.2011.00827.x","article-title":"Using quantitative polymerase chain reaction to correlate Chlamydia pecorum infectious load with ocular, urinary and reproductive tract disease in the koala (Phascolarctos cinereus)","volume":"89","author":"Wan","year":"2011","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.tim.2026.02.003_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.theriogenology.2021.03.016","article-title":"The effect of Chlamydia infection on koala (Phascolarctos cinereus) semen quality","volume":"167","author":"Hulse","year":"2021","journal-title":"Theriogenology"},{"key":"10.1016\/j.tim.2026.02.003_bb0110","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1038\/s41598-019-49382-9","article-title":"Longitudinal study of wild koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals","volume":"9","author":"Robbins","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2026.02.003_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2026.02.003_bb0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/mi.2007.19","article-title":"Chlamydia trachomatis infection: host immune responses and potential vaccines","volume":"1","author":"Hafner","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.tim.2026.02.003_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1101\/gr.7020108","article-title":"Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates","volume":"18","author":"Thomson","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.tim.2026.02.003_bb0130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10096-010-0959-2","article-title":"Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries","volume":"29","author":"Martin-Iguacel","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/509922","article-title":"Lymphogranuloma venereum in the United Kingdom","volume":"44","author":"Ward","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0140","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1093\/cid\/cir699","article-title":"Chlamydial and gonococcal infections in infants and children","volume":"53","author":"Hammerschlag","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tim.2026.02.003_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1478001","article-title":"Prevalence and associated factors of active trachoma among children of 1 to 9\u202fyears in low-income countries of Africa: a systematic review and meta-analysis","volume":"13","author":"Berhanu","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.tim.2026.02.003_bb0150","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1128\/JCM.00992-13","article-title":"Multilocus sequence analysis provides insights into molecular epidemiology of Chlamydia pecorum infections in Australian sheep, cattle, and koalas","volume":"51","author":"Jelocnik","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tim.2026.02.003_bb0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ng.2214","article-title":"Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing","volume":"44","author":"Harris","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tim.2026.02.003_bb0160","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pt.2020.08.006","article-title":"Ecological and evolutionary challenges for wildlife vaccination","volume":"36","author":"Barnett","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.tim.2026.02.003_bb0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nri3551","article-title":"Studying immunity to zoonotic diseases in the natural host\u2014keeping it real","volume":"13","author":"Bean","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2026.02.003_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41541-024-00938-5","article-title":"Immunisation of koalas against Chlamydia pecorum results in significant protection against chlamydial disease and mortality","volume":"9","author":"Phillips","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tim.2026.02.003_bb0175","article-title":"Veterinary and human vaccine evaluation methods","volume":"281","author":"Knight-Jones","year":"2014","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.tim.2026.02.003_bb0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetmic.2014.08.018","article-title":"Evaluation of the relationship between Chlamydia pecorum sequence types and disease using a species-specific multi-locus sequence typing scheme (MLST)","volume":"174","author":"Jelocnik","year":"2014","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.tim.2026.02.003_bb0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cmi.2022.02.013","article-title":"Call for consensus in Chlamydia trachomatis nomenclature: moving from biovars, serovars, and serotypes to genovariants and genotypes","volume":"28","author":"de Vries","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tim.2026.02.003_bb0190","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.vaccine.2012.12.057","article-title":"Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus)","volume":"31","author":"Kollipara","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/ece3.70973","article-title":"Dominance of vaccine-specific Chlamydia pecorum ompA genotypes in koalas from north-eastern Australia","volume":"15","author":"Sarovich","year":"2025","journal-title":"Ecol. Evol."},{"key":"10.1016\/j.tim.2026.02.003_bb0200","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2014.08.037","article-title":"Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses","volume":"32","author":"Khan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0205","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/microorganisms12061196","article-title":"Advances in Chlamydia trachomatis vaccination: unveiling the potential of major outer membrane protein derivative constructs","volume":"12","author":"Kiekens","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.tim.2026.02.003_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2020.12.001","article-title":"Polyphosphazene immunoadjuvants: historical perspective and recent advances","volume":"329","author":"Andrianov","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tim.2026.02.003_bb0215","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.vaccine.2017.05.067","article-title":"A novel combination adjuvant platform for human and animal vaccines","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.625482","article-title":"Polyphosphazenes as adjuvants for animal vaccines and other medical applications","volume":"9","author":"Chand","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tim.2026.02.003_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2012.01.021","article-title":"Administration of poly[di(sodium carboxylatoethylphenoxy)] phosphazene (PCEP) as adjuvant activated mixed Th1\/Th2 immune responses in pigs","volume":"146","author":"Dar","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.tim.2026.02.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156094","article-title":"Antibody and cytokine responses of koalas (Phascolarctos cinereus) vaccinated with recombinant chlamydial major outer membrane protein (MOMP) with two different adjuvants","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2026.02.003_bb0235","doi-asserted-by":"crossref","first-page":"30601","DOI":"10.1038\/s41598-025-13296-6","article-title":"Evaluation of Chlamydia pecorum major outer membrane protein vaccine a management tool in wild koala (Phascolarctos cinereus) populations","volume":"15","author":"Simpson","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2026.02.003_bb0240","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/jpids\/piae036","article-title":"Understanding the regulatory pathways used to develop, evaluate, authorize, and approve new drugs and vaccines in the United States","volume":"13","author":"Domachowske","year":"2024","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.tim.2026.02.003_bb0245","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMra2200583","article-title":"Understanding vaccine safety and the roles of the FDA and the CDC","volume":"386","author":"Meissner","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2026.02.003_bb0250","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.vaccine.2020.05.007","article-title":"A veterinary vaccine development process map to assist in the development of new vaccines","volume":"38","author":"Francis","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tim.2026.02.003_bb0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1751-0813.1987.tb06064.x","article-title":"Chlamydial disease in koalas","volume":"64","author":"Brown","year":"1987","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.tim.2026.02.003_bb0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0723-2020(97)80065-3","article-title":"Outer membrane protein A gene sequencing demonstrates the polyphyletic nature of koala Chlamydia pecorum isolates","volume":"20","author":"Jackson","year":"1997","journal-title":"Syst. Appl. Microbiol."},{"key":"10.1016\/j.tim.2026.02.003_bb0270","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.vaccine.2011.12.125","article-title":"Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology","volume":"30","author":"Kollipara","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074808","article-title":"Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infection","volume":"8","author":"Kollipara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2026.02.003_bb0280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.vaccine.2014.12.052","article-title":"Comparison of subcutaneous versus intranasal immunization of male koalas (Phascolarctos cinereus) for induction of mucosal and systemic immunity against Chlamydia pecorum","volume":"33","author":"Waugh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0285","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.vaccine.2015.07.029","article-title":"Vaccination of koalas with a prototype chlamydial vaccine is safe, does not increase the incidence of lymphoma-related disease and maybe associated with increased lifespan in captive koalas","volume":"33","author":"Hern\u00e1ndez-S\u00e1nchez","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0290","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.vaccine.2015.12.050","article-title":"Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine","volume":"34","author":"Khan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0295","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1038\/s41598-020-67208-x","article-title":"Vaccination of koalas during antibiotic treatment for Chlamydia-induced cystitis induces an improved antibody response to Chlamydia pecorum","volume":"10","author":"Phillips","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2026.02.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178786","article-title":"Immunization of a wild koala population with a recombinant Chlamydia pecorum major outer membrane protein (MOMP) or polymorphic membrane protein (PMP) based vaccine: new insights into immune response, protection and clearance","volume":"12","author":"Desclozeaux","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2026.02.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210245","article-title":"Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus)","volume":"14","author":"Nyari","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.tim.2026.02.003_bb0310","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1016\/j.vaccine.2013.09.029","article-title":"Vaccines against diseases transmitted from animals to humans: a one health paradigm","volume":"31","author":"Monath","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tim.2026.02.003_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2024.101750","article-title":"The role of real-world evidence for regulatory and public health decision-making for accelerated vaccine deployment\u2014a meeting report","volume":"85","author":"Bollaerts","year":"2024","journal-title":"Biologicals"},{"key":"10.1016\/j.tim.2026.02.003_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2020.1711058","article-title":"An oral bait vaccination approach for the Tasmanian devil facial tumor diseases","volume":"19","author":"Flies","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tim.2026.02.003_bb0325","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/vaccines10091384","article-title":"Bridging animal and human data in pursuit of vaccine licensure","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.tim.2026.02.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001804","article-title":"Pathogen evolution during vaccination campaigns","volume":"20","author":"Day","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tim.2026.02.003_bb0335","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1098\/rsif.2006.0207","article-title":"The evolutionary epidemiology of vaccination","volume":"4","author":"Gandon","year":"2007","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.tim.2026.02.003_bb0340","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41577-021-00567-2","article-title":"Using cross-species vaccination approaches to counter emerging infectious diseases","volume":"21","author":"Warimwe","year":"2021","journal-title":"Nat. Rev. Immunol."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X26000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X26000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:23:18Z","timestamp":1780935798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X26000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0966842X26000296"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2026.02.003","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Koalas first: lessons from a wildlife Chlamydia vaccine","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}